LAWRENCE, Mass., Nov. 9, 2012 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced that Jeffrey H. Burbank, Chief Executive Officer, will participate in the following schedule of investor conferences. Where possible, a webcast of the event will be made available at http://www.nxstage.com/ir.cfm at the time of each conference. (Logo: http://photos.prnewswire.com/prnh/20110503/MM94799LOGO ) Lazard Capital Markets 9th Annual Healthcare Conference Wednesday, November 14, 2012 at 11 a.m.ET The Pierre Hotel New York, NY24 thAnnual Piper Jaffray Healthcare ConferenceTuesday, November 27, 2012 at 9:30 a.m.ETThe New York Palace Hotel New York, NYAbout NxStage Medical NxStage Medical, Inc. (Nasdaq: NXTM) is a medical device company, headquartered in Lawrence, Massachusetts, USA, that develops, manufactures and markets innovative products for the treatment of end-stage renal disease, or ESRD, and acute kidney failure. For more information on NxStage and its products, please visit the company's website at http://www.nxstage.com. Forward-Looking Statements This release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this release that are not clearly historical in nature are forward-looking, and the words "anticipate," "believe," "expect," "estimate," "plan," and similar expressions are generally intended to identify forward-looking statements. Examples of these forward-looking statements include statements as to Mr. Burbank's plans to present at these conferences. NxStage specifically disclaims any obligation to update these forward-looking statements. These forward-looking statements should not be relied upon as representing NxStage's expectations or beliefs as of any date subsequent to the date of this press release.